Newsy's Latest Health News

The FDA has approved Remdesivir as the first drug to treat COVID-19, to be used for patients 12 or older and weighing at least 88 pounds who require hospitalization. It will be sold under the brand name Veklury and administered in hospitals. Tennessee has released a draft plan for distributing COVID-19 vaccines, prioritizing first responders and healthcare workers, with 10% reserved for high-risk areas. The majority of vaccines will be allocated based on county population.

What is the minimum age and weight requirement for patients to be treated with Remdesivir?

• 10 years and 80 pounds

• 12 years and 88 pounds

• 18 years and 100 pounds

• 15 years and 90 pounds

Under what brand name will Remdesivir be sold?

• Remcov

• Remdesi

• Veklury

• Covir

What was the significant finding of the federal study that led to the emergency use authorization of Remdesivir?

• It eliminated the need for hospitalization.

• It prevented COVID-19 infection.

• It reduced the recovery time for hospitalized COVID-19 patients.

• It increased the survival rate of COVID-19 patients.

How will Tennessee allocate the majority of its COVID-19 vaccines?

• Based on population

• Based on the number of hospitals

• Based on the number of healthcare workers

• Based on the number of COVID-19 cases

Who are prioritized in the initial phase of Tennessee's vaccine distribution plan?

• First responders and healthcare workers

• Elderly and children

• Teachers and students

• Politicians and government officials